Structures by: Jagadish B.
Total: 9
NH4,C25H44GdN4O8S,2H2O
NH4,C25H44GdN4O8S,2H2O
Journal of medicinal chemistry (2010) 53, 18 6747-6757
a=8.0364(13)Å b=10.4906(17)Å c=21.799(4)Å
α=76.573(3)° β=86.307(3)° γ=88.816(3)°
4''-cyano-7,7''-dimethoxy-3',6'-dioxodispiro[indane-2,2'-piperazine- 5',2''-indane]-4-carboxamide methanol solvate
C24H22N4O5,CH4O
Acta Crystallographica Section C (2008) 64, 8 o431-o433
a=9.6409(7)Å b=10.4629(8)Å c=25.5588(19)Å
α=90.00° β=90.00° γ=90.00°
(S,S)-Cyclo-bis(2-amino-4-methoxy-7-cyanoindan-2-carboxylic acid)
C24H20N4O4,3(C2H6OS)
Crystal Growth & Design (2003) 3, 5 811
a=16.4321(11)Å b=10.3701(7)Å c=12.2684(8)Å
α=90.00° β=130.2420(10)° γ=90.00°
(R,S)-Cyclo-bis(2-amino-7-cyanoindan-4-methoxy-2-carboxylic acid)
C24H20N4O4,3(C2H6OS)
Crystal Growth & Design (2003) 3, 5 811
a=21.156(3)Å b=8.8635(10)Å c=18.640(2)Å
α=90.00° β=110.286(2)° γ=90.00°
(R,S)-Cyclo-[phenylalanine-(2-amino-7-cyano -4-methoxyindan-2-carboxylic acid)
C21H19N3O3
Crystal Growth & Design (2003) 3, 5 811
a=11.042(4)Å b=6.121(2)Å c=13.549(5)Å
α=90.00° β=104.805(7)° γ=90.00°
(S,S)-Cyclo-[phenylalanine-(2-amino-7-cyano -4-methoxyindan-2-carboxylic acid)
C21H19N3O3
Crystal Growth & Design (2003) 3, 5 811
a=10.9128(12)Å b=6.0767(7)Å c=13.7533(15)Å
α=90.00° β=94.080(2)° γ=90.00°
(S,S)-Cyclo-bis(2-amino-7-cyanoindan-4-methoxy-2-carboxylic acid)
C24H20N4O4,2(C6H14OS)
Crystal Growth & Design (2003) 3, 5 811
a=10.0589(7)Å b=13.1580(9)Å c=15.7738(11)Å
α=70.1270(10)° β=76.4190(10)° γ=78.1610(10)°
(R,R),(S,S)-Cyclo-bis(2-amino-4-methoxy-7-cyanoindan-2-carboxylic acid)
C24H20N4O4,3(C2H6OS)
Crystal Growth & Design (2003) 3, 5 811
a=19.919(3)Å b=11.9916(19)Å c=28.951(5)Å
α=90.00° β=108.562(3)° γ=90.00°
Cyclo-bis(4-cyano-7-methoxy-2-aminoindan-2-carboxylic acid)
(C24H20N4O4)(C2H6OS)3
Crystal Growth & Design (2003) 3, 5 811
a=16.526(2)Å b=10.3837(14)Å c=12.3259(17)Å
α=90.00° β=130.402(2)° γ=90.00°